AVTX 8-K 2026-01-12

Avalo Therapeutics, Inc. (AVTX) 8-K dated 2026-01-12 — accession 0001534120-26-000003. This URL is the filing, not the AVTX hub.

Avalo Therapeutics, Inc. (AVTX) is a biotechnology company listed on US.

Avalo Therapeutics, Inc. filed a 8-K on 2026-01-12. Accession 0001534120-26-000003.

Cached items: 2.02, 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.

Not investment advice. The AVTX SEC hub lists recent forms. The stock page is the research view.